Literature DB >> 19908383

Improving the prediction of pharmacogenes using text-derived drug-gene relationships.

Yael Garten1, Nicholas P Tatonetti, Russ B Altman.   

Abstract

A critical goal of pharmacogenomics research is to identify genes that can explain variation in drug response. We have previously reported a method that creates a genome-scale ranking of genes likely to interact with a drug. The algorithm uses information about drug structure and indications of use to rank the genes. Although the algorithm has good performance, its performance depends on a curated set of drug-gene relationships that is expensive to create and difficult to maintain. In this work, we assess the utility of text mining in extracting a network of drug-gene relationships automatically. This provides a valuable aggregate source of knowledge, subsequently used as input into the algorithm that ranks potential pharmacogenes. Using a drug-gene network created from sentence-level co-occurrence in the full text of scientific articles, we compared the performance to that of a network created by manual curation of those articles. Under a wide range of conditions, we show that a knowledge base derived from text-mining the literature performs as well as, and sometimes better than, a high-quality, manually curated knowledge base. We conclude that we can use relationships mined automatically from the literature as a knowledgebase for pharmacogenomics relationships. Additionally, when relationships are missed by text mining, our system can accurately extrapolate new relationships with 77.4% precision.

Entities:  

Mesh:

Year:  2010        PMID: 19908383      PMCID: PMC3092476          DOI: 10.1142/9789814295291_0033

Source DB:  PubMed          Journal:  Pac Symp Biocomput        ISSN: 2335-6928


  27 in total

1.  Pharmacogenomics--drug disposition, drug targets, and side effects.

Authors:  William E Evans; Howard L McLeod
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

Review 2.  The microeconomics of personalized medicine: today's challenge and tomorrow's promise.

Authors:  Jerel C Davis; Laura Furstenthal; Amar A Desai; Troy Norris; Saumya Sutaria; Edd Fleming; Philip Ma
Journal:  Nat Rev Drug Discov       Date:  2009-03-20       Impact factor: 84.694

3.  The effect of variable CYP3A5 expression on cyclosporine dosing, blood pressure and long-term graft survival in renal transplant patients.

Authors:  Reinhold Kreutz; Heiko Zürcher; Silke Kain; Peter Martus; Gerd Offermann; Joachim Beige
Journal:  Pharmacogenetics       Date:  2004-10

Review 4.  Pharmacogenetics goes genomic.

Authors:  David B Goldstein; Sarah K Tate; Sanjay M Sisodiya
Journal:  Nat Rev Genet       Date:  2003-12       Impact factor: 53.242

5.  Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.

Authors:  Stephen Jones; Frankie Ann Holmes; Joyce O'Shaughnessy; Joanne L Blum; Svetislava J Vukelja; Kristi J McIntyre; John E Pippen; James H Bordelon; Robert L Kirby; John Sandbach; William J Hyman; Donald A Richards; Robert G Mennel; Kristi A Boehm; Wally G Meyer; Lina Asmar; Daniel Mackey; Stefan Riedel; Hyman Muss; Michael A Savin
Journal:  J Clin Oncol       Date:  2009-02-09       Impact factor: 44.544

6.  Generating genome-scale candidate gene lists for pharmacogenomics.

Authors:  N T Hansen; S Brunak; R B Altman
Journal:  Clin Pharmacol Ther       Date:  2009-04-15       Impact factor: 6.875

7.  Antidepressant switching among adherent patients treated for depression.

Authors:  Steven C Marcus; Mariam Hassan; Mark Olfson
Journal:  Psychiatr Serv       Date:  2009-05       Impact factor: 3.084

8.  CYP3A5 genotype is associated with longer patient survival after kidney transplantation and long-term treatment with cyclosporine.

Authors:  R Kreutz; J Bolbrinker; F van der Sman-de Beer; E W Boeschoten; F W Dekker; S Kain; P Martus; A Sietmann; F Friedrichs; M Stoll; G Offermann; J Beige
Journal:  Pharmacogenomics J       Date:  2008-01-08       Impact factor: 3.550

9.  Pharmspresso: a text mining tool for extraction of pharmacogenomic concepts and relationships from full text.

Authors:  Yael Garten; Russ B Altman
Journal:  BMC Bioinformatics       Date:  2009-02-05       Impact factor: 3.169

10.  A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose.

Authors:  Fumihiko Takeuchi; Ralph McGinnis; Stephane Bourgeois; Chris Barnes; Niclas Eriksson; Nicole Soranzo; Pamela Whittaker; Venkatesh Ranganath; Vasudev Kumanduri; William McLaren; Lennart Holm; Jonatan Lindh; Anders Rane; Mia Wadelius; Panos Deloukas
Journal:  PLoS Genet       Date:  2009-03-20       Impact factor: 5.917

View more
  16 in total

1.  A knowledge-driven conditional approach to extract pharmacogenomics specific drug-gene relationships from free text.

Authors:  Rong Xu; Quanqiu Wang
Journal:  J Biomed Inform       Date:  2012-04-27       Impact factor: 6.317

Review 2.  Recent progress in automatically extracting information from the pharmacogenomic literature.

Authors:  Yael Garten; Adrien Coulet; Russ B Altman
Journal:  Pharmacogenomics       Date:  2010-10       Impact factor: 2.533

3.  Learning from biomedical linked data to suggest valid pharmacogenes.

Authors:  Kevin Dalleau; Yassine Marzougui; Sébastien Da Silva; Patrice Ringot; Ndeye Coumba Ndiaye; Adrien Coulet
Journal:  J Biomed Semantics       Date:  2017-04-20

4.  Mining the pharmacogenomics literature--a survey of the state of the art.

Authors:  Udo Hahn; K Bretonnel Cohen; Yael Garten; Nigam H Shah
Journal:  Brief Bioinform       Date:  2012-07       Impact factor: 11.622

Review 5.  Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review.

Authors:  Peter Csermely; Tamás Korcsmáros; Huba J M Kiss; Gábor London; Ruth Nussinov
Journal:  Pharmacol Ther       Date:  2013-02-04       Impact factor: 12.310

6.  Teaching computers to read the pharmacogenomics literature ... so you don't have to.

Authors:  Yael Garten; Russ B Altman
Journal:  Pharmacogenomics       Date:  2010-04       Impact factor: 2.533

Review 7.  Progress towards the integration of pharmacogenomics in practice.

Authors:  Sean D Mooney
Journal:  Hum Genet       Date:  2014-09-11       Impact factor: 4.132

8.  Discovering drug-drug interactions: a text-mining and reasoning approach based on properties of drug metabolism.

Authors:  Luis Tari; Saadat Anwar; Shanshan Liang; James Cai; Chitta Baral
Journal:  Bioinformatics       Date:  2010-09-15       Impact factor: 6.937

9.  Combining heterogenous data for prediction of disease related and pharmacogenes.

Authors:  Christopher S Funk; Lawrence E Hunter; K Bretonnel Cohen
Journal:  Pac Symp Biocomput       Date:  2014

10.  Using PharmGKB to train text mining approaches for identifying potential gene targets for pharmacogenomic studies.

Authors:  S Pakhomov; B T McInnes; J Lamba; Y Liu; G B Melton; Y Ghodke; N Bhise; V Lamba; A K Birnbaum
Journal:  J Biomed Inform       Date:  2012-05-04       Impact factor: 6.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.